Elizabeth Donley Named Chair of M3 Insurance Board of Directors

Elizabeth L.R. Donley, CEO at Stemina Biomarker Discovery, was named chair of the board of directors for M3 Insurance at the M3 board meeting on March 2, 2022. Donley has served on the M3 board since October, 2013, and fills the chair position vacated by Corey A. Chambas, president and CEO at First Business Financial Services, Inc. Chambas will continue to serve as an advisor to the board.

Donley becomes the 4th board chair in M3’s 54-year history, succeeding Chambas who has served on the board since 2004. In 2013, Chambas became the first individual outside of M3 employment to serve as chair of the board, and has served in that position for the past nine years, providing leadership and innovation to grow and build what is now a top brokerage in America.

“We are incredibly grateful to both Corey and Beth for their loyal service and commitment to M3. The leadership, guidance and strategy they provide play an integral role in our forward-thinking, client-focused mindset.”

— Mike Victorson, CEO | M3 Insurance

About M3

M3 is a top insurance broker and risk management firm in America. We’re leaders in the products we represent and the industries we serve. M3’s people are an extension of your team, providing world-class resources to help you manage risk, purchase insurance, and provide employee benefits. And our focus on community builds better places to live and work.

Local EXIT Realty Affiliated Offices Welcome New Team Members

FOR IMMEDIATE RELEASE

Contact:
Susan Harrison
Senior Vice President
EXIT Realty Corp. International
sharrison@exitrealty.com
888-668-3948

Local EXIT Realty Affiliated Offices Welcome New Team Members

Madison, WI (Grassroots Newswire) March 10, 2022 – EXIT Realty HGM is pleased to announce that Glorian Rangel, Erica Lee and Miguel Meza Zelaya have joined its growing team of dedicated real estate sales professionals.

EXIT Realty HGM, located at 4211 W. Beltline Hwy, Madison, Wisconsin is a proud member of EXIT Realty Upper Midwest’s rapidly expanding network of independently owned and operated brokerages across the region.

About EXIT Realty: EXIT Realty is a company founded and built on human potential. A full service, forward-thinking, real estate franchisor with offices across North America, EXIT has to-date paid out more than a half a billion dollars in single-level residual income to its associates. The Expert Marketing Suite^™ including geolocation Smart Sign^™ technology gives sellers an edge in a competitive marketplace. A portion of every transaction fee received by EXIT Realty Corp. International is applied to its charitable fund, and to-date, $6.8 million has been allocated to charity. For more information, please visit www.exitrealty.com and www.joinexitrealty.com.

# # #

Luminex Job Posting: Senior Director/Vice President, Assay Research and Development – US

Luminex, a DiaSorin Company is seeking dedicated and talented individuals with a proactive and positive ‘can-do’ attitude to join our team. If changing the diagnostic landscape and revolutionizing patient care sounds like something you would like to be a part of, we invite you to apply today!  Together, we can help healthcare providers improve patient outcomes,  make a difference in fighting the COVID-19 outbreak, and tackle the world’s most pressing health issues.   You can learn more about our values, mission, and vision by visiting our website: https://www.luminexcorp.com/about-luminex/.

The Senior Director/Vice President of Assay Research and Development is responsible for managing a department focused on researching and developing new product ideas geared towards development of in vitro diagnostic products. The role necessitates close collaboration with departments across the company, including Marketing, Manufacturing, Regulatory, Quality and Technical Support. The position leads evaluation, feasibility, and product development activities of new products and technologies in accordance with Design Control Standards and Regulations. The Senior Director of Assay Research and Development is also responsible for administrative duties pertaining to the department as a whole, managing departmental project timelines, and preparing and monitoring the departmental fiscal year budget.

What you will do

• Direct and manage a department responsible for the development of new and improved products to meet corporate objectives and timelines
• Direct scientific managers and their group of scientists and associates in the development of new and improved in vitro diagnostic products in accordance with Quality System Requirements.
• In collaboration with marketing, establish effective pipeline plans and schedules to ensure timely progress of multiple products through all phases of new product development. Manage project team leaders from feasibility through development phase of product development and ensure effective knowledge transfer between feasibility and development groups.
• Provide department leadership for maintaining awareness of current advances in clinical diagnostic technology and literature (including regulations and standards) pertaining to nucleic acid based methods to ensure pipeline development plans capture all relevant considerations
• Provide leadership within Research & Development and across the organization in order to foster employee development
• Contribute towards management of GMP, GLP and GCP processes relating to design control, design change, and design transfer
• Direct verification and validation testing of new products in agreement with design control requirements.
• Contribute towards pre-submission activities and oversee clinical studies for the purpose of collecting data to support submissions to regulatory agencies (e.g. FDA, Health Canada)
• Oversee design transfer of products from Product Development to Operations
• Interact with Regulatory, Operations and Marketing to efficiently and effectively manage development, transfer and launch of a portfolio of diagnostic products
• Provide scientific expertise and support for on-market products. Lead troubleshooting activities and product design changes for on-market products.
• Role in Technology Assessment, Opportunity teams (review of new opportunities) and scientific development in the diagnostic field.
• Prepare departmental budgets and establish equipment and personnel needs to provide for product development.

Education Qualifications

• Ph.D. Ph.D. in Molecular Biology, Biochemistry or a related field. required

Experience Qualifications

• 10+ Years in scientific work in a biotechnology or other research environment. required
• 5+ Years Experience in nucleic acid amplification technologies (e.g. PCR), and molecular sample-to-answer systems. required
• 5+ Years leading and/or managing a team of engineers, scientists, associates and technicians in meeting department deliverables on a day-to-day basis required
• 5+ Years Experience in diagnostic assay development in a GLP/GMP environment required
• 5+ Years Experience preparing and working within budgets required
• 5+ Years Experience working in a fast-paced environment with rapidly changing priorities. required

Training and Skills

• Ability to advance projects through to completion, managing expectations and timelines, and meeting key milestones
• Demonstrates good judgment and good decision-making, sometimes quickly and with limited information available
• Capacity to manage several projects in parallel to ensure maximum productivity, without compromising quality, in pipeline development
• Exceptional verbal and written communication skills
• Ability to interact effectively with Senior Management
• Proven ability to lead and manage teams while maintaining a positive, energetic and collaborative culture

Standard Working Conditions

• Must work onsite at Luminex office – Frequently

Travel Requirements

• 10% with 5% international

Luminex Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, age, national origin, disability status of an otherwise qualified individual, citizenship status, membership or application for membership in a uniformed service, or any other protected characteristic or category protected by applicable law.

Henrich Named to M3 Insurance Board of Directors

Kathy Henrich, CEO of Milwaukee Tech Hub Coalition, has been named to the Board of Directors of M3 Insurance. Henrich’s three-year board appointment was approved on March 2, 2022, at the M3 Shareholder Meeting.

In January 2020, Henrich was named CEO of Milwaukee Tech Hub Coalition, a non-profit organization focused on inclusively doubling tech talent in the Milwaukee region to drive regional prosperity and create life changing jobs. Since its inception in October 2019, the coalition has grown from six founding members to 115 organizations collaborating to attract and build diverse tech talent, scale the innovation ecosystem and connect the tech community. In her tenure, the coalition has launched a startup incubator, corporation innovation, internship, apprenticeship, and talent attraction programs.

Prior to joining Milwaukee Tech Hub Coalition, Henrich served for more than 30 years in the tech industry, leading $500M sales, partnership, and consulting organizations. She earned her Master of Science, Workforce Talent Development from Louisiana State University, and a certificate in Data Driven Consulting from the Kellogg School of Management at Northwestern University. Additionally, Henrich serves on boards of several non-profit organizations, including Tech United, WI Startup Coalition, and Wisconsin Policy Forum Economic Development Committee.

“We are honored and excited to bring Kathy’s talent, experience and perspective to the M3 board,” said Mike Victorson, M3 CEO. “Her leadership and vision around technology and advancing innovation will undoubtedly benefit all stakeholders connected with M3 as we continue to grow and evolve as a forward-thinking, client-driven organization.”

---

About M3

M3 is a top insurance broker and risk management firm in America. We’re leaders in the products we represent and the industries we serve. M3’s people are an extension of your team, providing world-class resources to help you manage risk, purchase insurance, and provide employee benefits. And our focus on community builds better places to live and work.

James C. Boll joins NGL as Vice President, Deputy General Counsel

Madison, Wis. (February 24, 2022) – National Guardian Life Insurance Company (NGL) is pleased to welcome James C. Boll to the team as Vice President, Deputy General Counsel and Deputy Corporate Secretary, Boll has 30 years of legal experience, including litigation and corporate, as well as insurance operations and regulation. Boll joins NGL’s leadership team and will be managing corporate legal operations.

“We are excited for Jim to join us at NGL. His legal expertise and insurance experience coupled with management will be a valuable asset for us as we look toward future growth and expansion,” said Kim Shaul, NGL Senior Vice President, Chief Legal Officer.

Boll is a former President of the State Bar of Wisconsin and former Board Member of the Dane County Bar Association. His insurance experience includes positions as General Counsel for the Wisconsin Office of Commissioner of Insurance and as litigation counsel for a major insurance company.

Boll has held numerous supervisory positions as senior corporate counsel for a utility company and, most recently, as founding partner of the law firm St. Marie Boll, LCC. He has extensive experience negotiating contracts, developing budgets, supervising outside counsel and managing legal staff.

“I appreciate the opportunity to join NGL during an exciting time of transition and growth,” said Boll. “NGL is a successful, one hundred-year-old insurance company that is committed to serving policyholders and helping them when they need it most. I look forward to working with the legal team as we advise the business units on legal and compliance obligations.”

Boll holds a Juris Doctor from Marquette University Law School. He also has a Bachelor of Science in Political Science from University of Wisconsin-Madison. Boll has received numerous awards and honors, including twice being honored with the State Bar of Wisconsin President’s Award for Outstanding Service to the Bar, as well as receiving the Wisconsin Judicial Council Recognition of Service. He maintains a Martindale-Hubbell – AV Preeminent Rating (highest possible rating in both legal ability and ethical standards).

As an active member of the community, Boll has also held several appointments with the City of Madison, coached youth basketball and football, and served as a Board Director for Attic Angels Prairie Point Retirement Community and Montessori Children’s House.

Boll is married with two adult sons and is a proud supporter of Madison Memorial Spartan athletics.

About NGL

Established in 1909 National Guardian Life Insurance Company (NGL) is an insurance company headquartered in Madison, Wis. Licensed to do business in 49 states and the District of Columbia, NGL markets preneed and individual life and annuities, as well as group markets products. Information about NGL can be found at www.nglic.com; Facebook: Facebook.com/NGLIC and LinkedIn: https://www.linkedin.com/company/national-guardian-life-insurance-company.

National Guardian Life Insurance Company is not affiliated with The Guardian Life Insurance Company of America a/k/a The Guardian or Guardian Life.

###